Evolent Health Inc
Suletud
SektorTervishoid
4.79 1.91
Ülevaade
Aktsiahinna muutus
24h
Min
4.5
Max
4.9
Sissetulek | -28M -55M |
|---|---|
Müük | 156M 653M |
Aktsiakasum | -0.11 |
Kasumimarginaal | -8.428 |
Töötajad | 4,200 |
EBITDA | -856K 13M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +31% upside |
Turukapital | 150M 503M |
|---|---|
Eelmine avamishind | 2.88 |
Eelmine sulgemishind | 4.79 |
Evolent Health Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Evolent Health Inc Prognoos
Hinnasiht
By TipRanks
31% tõus
12 kuu keskmine prognoos
Keskmine 6 USD 31%
Kõrge 8 USD
Madal 3 USD
Põhineb 9 Wall Streeti analüütiku instrumendi Evolent Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.